Perceptive Advisors LLC Intercept Pharmaceuticals, Inc. Transaction History

Perceptive Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $4.72 Million - $11.6 Million	-97,600 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $7.59 Million - $11.8 Million	97,600 New	97,600 $7.77 Million
Q4 2018 Feb 14, 2019	SELL	$85.79 - $126.46 $482,740 - $711,590	-5,627 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$88.49 - $127.55 $497,933 - $717,723	5,627 New	5,627 $711,000
Q4 2017 Feb 14, 2018	SELL	$58.2 - $72.76 $5.24 Million - $6.55 Million	-90,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $5.13 Million - $10.7 Million	90,000	90,000 $5.22 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.